Tag

• admin
• advanced cancer therapy cancer care access India cancer immunotherapy India checkpoint inhibitor drugs immunotherapy risks Keytruda drug oncology treatment cost PD-1 inhibitors pembrolizumab therapy UPSC health science
• 14
• 0

Keytruda Immunotherapy: Mechanism, Cost, Risks, and Access

Keytruda Immunotherapy: Mechanism, Cost, Risks, and Access Why in the News ? The drug Keytruda is in focus after an investigation revealed a rising counterfeit market in India, along with concerns over its high cost, limited accessibility, and regulatory gaps, amid increasing cancer burden and growing demand for advanced immunotherapy treatments. Keytruda and Immunotherapy: Working …

Read More